CDMO News News and Resources

SteriPack, a global contract design and manufacturing organisation (CDMO) for the pharmaceutical and medical device industries, has announced a change in its trading name to Ensera. The rebrand marks a strategic evolution of the company’s identity and service offering, positioning

Rentschler Biopharma SE marked the progress of its new buffer media station at its Laupheim headquarters with a time capsule ceremony and panel discussion on October 10, 2025. The project represents the largest single investment in the company’s history at

LTS LOHMANN Therapie-Systeme AG (LTS) has announced the acquisition of Renaissance Lakewood, LLC, a United States-based contract development and manufacturing organisation (CDMO) that specialises in nasal sprays and sterile dosage forms. The deal is expected to close before the end

C-Ray Therapeutics (Chengdu) Co.,Ltd has played a central role in advancing Biokin Pharmaceutical’s first radiopharmaceutical, [177Lu]-BL-ARC001 Injection, following implied approval from China’s National Medical Products Administration (NMPA) for clinical trials. The milestone represents Biokin’s entry into the Radiopharmaceutical Drug Conjugate

Jubilant Pharmova Limited has expanded its North American contract manufacturing operations with the successful launch of a third sterile injectable line at its Spokane, Washington, facility. Operated by wholly owned subsidiary Jubilant HollisterStier (JHS), the new line began production with

IAVI has announced a strategic partnership with Minapharm and ProBioGen to advance vaccine and biologics development and manufacturing on the African continent. The collaboration focuses on building regional capacity to produce priority vaccines and monoclonal antibodies (mAbs) through contract manufacturing

GC Biopharma has announced an agreement with Curevo Vaccine to secure contract manufacturing (CMO) rights for amezosvatein (CRV-101), a recombinant shingles vaccine currently in clinical development. Under the terms of the deal, GC Biopharma will produce part of the commercial

Samsung Biologics has unveiled ExellenS™, an optimised manufacturing framework designed to enhance performance and consistency across its global biomanufacturing network. Developed through the company’s accumulated expertise in plant design, digitalisation, and operational excellence, ExellenS™ standardises equipment, processes, and functional specifications

Lisata Therapeutics, Inc. has announced a global licensing agreement with Catalent, Inc., enabling Catalent to incorporate Lisata’s proprietary certepetide into antibody-drug conjugates (ADCs) developed using Catalent’s SMARTag® technology platform. Certepetide is an internalizing RGD (“iRGD”) cyclic peptide currently being tested

Recipharm, a global CDMO, has announced the designation of its Cuxhaven facility in Germany as the Centre of Excellence for Analytical Services tailored to advanced modalities. The site features newly renovated 500 m² GMP analytical laboratories designed to support both